鹰瞳科技-B(02251)下跌5.79%，报11.06元/股

金融界09-30

9月30日，鹰瞳科技-B(02251)盘中下跌5.79%，截至15:20，报11.06元/股，成交155.19万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2471779829?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-30 15:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2471779829","market":"us","top_or_hot":-1,"title":"鹰瞳科技-B(02251)下跌5.79%，报11.06元/股","media":"金融界","content":"<div>\n<p>9月30日，鹰瞳科技-B(02251)盘中下跌5.79%，截至15:20，报11.06元/股，成交155.19万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、...</p>\n\n<a href=\"https://hk.jrj.com.cn/2024/09/30152043653949.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>鹰瞳科技-B(02251)下跌5.79%，报11.06元/股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n鹰瞳科技-B(02251)下跌5.79%，报11.06元/股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-30 15:20 北京时间&nbsp;&nbsp;&nbsp;<a href=https://hk.jrj.com.cn/2024/09/30152043653949.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>9月30日，鹰瞳科技-B(02251)盘中下跌5.79%，截至15:20，报11.06元/股，成交155.19万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、...</p>\n\n<a href=\"https://hk.jrj.com.cn/2024/09/30152043653949.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1189","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://hk.jrj.com.cn/2024/09/30152043653949.shtml","article_id":"2471779829","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2471779829","pubTimestamp":1727680827,"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"9月30日，鹰瞳科技-B(02251)盘中下跌5.79%，截至15:20，报11.06元/股，成交155.19万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、保险公司、视光中心及药房等场所，为用户提供疾病辅助诊断及健康风险评估。截至2024年中报，鹰瞳科技-B营业总收入9371.0万元、净利润-8050.2万元。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1189":"医疗保健技术","02251":"鹰瞳科技-B"},"translate_title":"Eagle Eye Technology-B (02251) fell 5.79% to 11.06 yuan per share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02251":1},"content_text":"9月30日，鹰瞳科技-B(02251)盘中下跌5.79%，截至15:20，报11.06元/股，成交155.19万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案，特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品，已广泛应用于社区诊所、体检中心、保险公司、视光中心及药房等场所，为用户提供疾病辅助诊断及健康风险评估。截至2024年中报，鹰瞳科技-B营业总收入9371.0万元、净利润-8050.2万元。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2471779829"}